FLUANXOL DEPOT 2% -LIQ IM 20MG/ML 20 MG
FLUPENTIXOL DECANOATE : 20 MG · DIN 02156032 · LUNDBECK CANADA INC
Health Canada status: MARKETED
What is FLUANXOL DEPOT 2% -LIQ IM 20MG/ML?
FLUANXOL DEPOT 2% -LIQ IM 20MG/ML 20 MG contains FLUPENTIXOL DECANOATE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02156032, held by LUNDBECK CANADA INC, supplied as SOLUTION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 31-Dec-1995. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02156032 |
|---|---|
| Brand name | FLUANXOL DEPOT 2% -LIQ IM 20MG/ML |
| Generic / active ingredient | FLUPENTIXOL DECANOATE : 20 MG |
| Manufacturer | LUNDBECK CANADA INC |
| Strength | 20 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | N05AF01 FLUPENTIXOL |
| AHFS class | 28:16.08.32 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1995 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N05AF01 FLUPENTIXOL. 4 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLUANXOL 0.5MG - TAB | 0.5 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02156008 |
| FLUANXOL 3MG - TAB | 3 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02156016 |
| FLUANXOL DEPOT 10%- LIQ IM 100MG/ML | 100 MG | SOLUTION | LUNDBECK CANADA INC | MARKETED | DIN 02156040 |
| FLUANXOL DEPOT INJ 100MG/ML | 100 MG | LIQUID | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00524530 |
| FLUANXOL DEPOT INJ 20MG/ML | 20 MG | LIQUID | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00524522 |
| FLUANXOL TAB 0.5MG | 0.5 MG | TABLET | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00580619 |
| FLUANXOL TAB 3MG | 3 MG | TABLET | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00585157 |
| FLUPENTIXOL DECANOATE INJECTION BP | 100 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02331721 |
| FLUPENTIXOL DECANOATE INJECTION BP | 20 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02331713 |
Who else supplies FLUPENTIXOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUPENTIXOL appears in 25 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.